Court Sides With FTC Finding Illumina-Grail Deal Anticompetitive
A federal appeals court said the U.S. government was right to challenge Illumina’s purchase of cancer-test developer Grail, but still...
LINK|i4-WP-WSJ-0001436781
MORNING TOP NEWS AND BLOG
